Ursprung des Netzwerks ersten Grades von Steve Daly
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Abvance Therapeutics, Inc.
 Abvance Therapeutics, Inc. BiotechnologyHealth Technology Abvance Therapeutics, Inc. is a pharmaceutical company that aims to improve diabetes control and reduce the risk of hypoglycemia. The company is based in Reno, NV. The company's Abv100 platform is designed to replace rapid acting insulin and can be used by any patient type, including those with type 1 and type 2 diabetes who use injections or pumps. The platform protects against hypoglycemia, allowing for safer use of insulin and better control of diabetes, which can lead to improved long-term health outcomes. The company was founded in 2016 by Alan Cherrington, David Maggs, and Soumitra Ghosh. David Maggs has been the CEO since 2016.
1
| Holding Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Steve Daly
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of London | College/University | Doctorate Degree | |
| GI DYNAMICS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Parke, Davis & Co. LLC | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Maggs | 5 |
- Börse
- Insiders
- Steve Daly
- Unternehmensverbindungen
